Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Association between serum testosterone levels, body mass index (BMI) and insulin in male patients with schizophrenia treated with atypical antipsychotics--olanzapine or risperidone.

Konarzewska B, Galińska-Skok B, Waszkiewicz N, Łazarczyk-Kirejczyk J, Malus A, Simonienko K, Szulc A.

Neuro Endocrinol Lett. 2014;35(1):50-7.

PMID:
24625910
2.

Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia.

Konarzewska B, Wołczyński S, Szulc A, Galińska B, Popławska R, Waszkiewicz N.

Psychoneuroendocrinology. 2009 Jan;34(1):129-39. doi: 10.1016/j.psyneuen.2008.08.015. Epub 2008 Oct 5.

PMID:
18838228
3.

Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.

Smith RC, Lindenmayer JP, Davis JM, Kelly E, Viviano TF, Cornwell J, Hu Q, Khan A, Vaidhyanathaswamy S.

J Clin Psychiatry. 2009 Nov;70(11):1501-13. doi: 10.4088/JCP.08m04446yel. Epub 2009 Oct 6.

PMID:
19814947
4.

Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone.

Konarzewska B, Waszkiewicz N, Galińska B, Szulc A.

Neuro Endocrinol Lett. 2013;34(4):322-8.

PMID:
23803867
5.

Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.

Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA.

Psychoneuroendocrinology. 2006 Jun;31(5):577-88. Epub 2006 Feb 20.

PMID:
16488084
6.

Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.

Yasui-Furukori N, Saito M, Nakagami T, Sugawara N, Sato Y, Tsuchimine S, Furukori H, Kaneko S.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):537-40. doi: 10.1016/j.pnpbp.2010.02.014. Epub 2010 Feb 17.

PMID:
20170699
7.

Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.

Wampers M, Hanssens L, van Winkel R, Heald A, Collette J, Peuskens J, Reginster JY, Scheen A, De Hert M.

Eur Neuropsychopharmacol. 2012 Jan;22(1):17-26. doi: 10.1016/j.euroneuro.2011.03.010. Epub 2011 Apr 20.

PMID:
21511441
8.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28.

PMID:
15630069
9.

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.

Kim KS, Pae CU, Chae JH, Bahk WM, Jun TY, Kim DJ, Dickson RA.

J Clin Psychiatry. 2002 May;63(5):408-13.

PMID:
12019665
10.

Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.

Yasui-Furukori N, Sato Y, Furukori H, Saito M, Nakagami T, Kaneko S.

J Clin Psychiatry. 2009 Jan;70(1):95-100.

PMID:
19026267
11.

The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.

Kinon BJ, Stauffer VL, McGuire HC, Kaiser CJ, Dickson RA, Kennedy JS.

J Am Med Dir Assoc. 2003 Jul-Aug;4(4):189-94.

PMID:
12837139
12.

Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.

Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung WP, Klingmüller D, Lemke MR, Maier W, Schubert M, Sträter B, Kühn KU.

J Sex Med. 2008 Dec;5(12):2816-26. doi: 10.1111/j.1743-6109.2008.00859.x. Epub 2008 May 7.

PMID:
18466271
13.

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.

Byerly MJ, Marcus RN, Tran QV, Eudicone JM, Whitehead R, Baker RA.

Schizophr Res. 2009 Feb;107(2-3):218-22. doi: 10.1016/j.schres.2008.09.019. Epub 2008 Nov 26.

PMID:
19038534
14.
15.

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B.

J Clin Psychiatry. 2003 May;64(5):598-604.

PMID:
12755665
16.

Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.

Jeong HG, Lee MS, Lee HY, Ko YH, Han C, Joe SH.

Int Clin Psychopharmacol. 2012 Jul;27(4):177-83. doi: 10.1097/YIC.0b013e328351c8c4.

PMID:
22407277
17.

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients.

Misiak B, Frydecka D, Łaczmański Ł, Ślęzak R, Kiejna A.

Eur J Clin Pharmacol. 2014 Dec;70(12):1433-41. doi: 10.1007/s00228-014-1762-2. Epub 2014 Oct 8.

18.

Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.

Wu RR, Zhao JP, Liu ZN, Zhai JG, Guo XF, Guo WB, Tang JS.

Psychopharmacology (Berl). 2006 Jul;186(4):572-8. Epub 2006 Apr 7.

PMID:
16601995
19.
20.

A crossover study on lipid and weight changes associated with olanzapine and risperidone.

Su KP, Wu PL, Pariante CM.

Psychopharmacology (Berl). 2005 Dec;183(3):383-6. Epub 2005 Oct 21.

PMID:
16240162

Supplemental Content

Support Center